← Back to Search

Behavioural Intervention

Nature Walks for Stress Management

Phase 1
Recruiting
Research Sponsored by Charlotte Tate
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18 years or older
Able-bodied as in must be able to walk
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (pre-intervention), during intervention, immediate post-intervention, 3 months after intervention
Awards & highlights

Study Summary

This trial aims to reduce stress in 4 ethnic/racial groups to reduce health disparities using nature-based activities.

Who is the study for?
This trial is for adults over 18 who speak English, Spanish, or Tagalog and can walk. They must commit to a 9-month program involving nature walks and activities. It's not for pregnant individuals, prisoners, or those with cognitive impairments.Check my eligibility
What is being tested?
The study tests if community nature walks followed by chosen nature activities can reduce stress in Black, Latinx, Pilipinx, and Pacific Islander groups to prevent health disparities using biological and behavioral measures.See study design
What are the potential side effects?
Since the intervention involves non-medical activities like walking in nature and family outings outdoors, there are no direct medical side effects expected from participating in this trial.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I can walk on my own.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (pre-intervention), during intervention, immediate post-intervention, 3 months after intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (pre-intervention), during intervention, immediate post-intervention, 3 months after intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Relative Telomere Length
Secondary outcome measures
Hair cortisol concentration
Positive mood (extent of)
Self-reported stress (extent of)
Other outcome measures
Heart rate (average of beats per minute over days)
Sleep quality (extent of)
Steps (number of)

Trial Design

1Treatment groups
Experimental Treatment
Group I: Waitlist ControlExperimental Treatment1 Intervention
Waitlist control; all participants receive the treatment but are in a control condition prior to the treatment

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

Charlotte TateLead Sponsor
University of California, San FranciscoOTHER
2,507 Previous Clinical Trials
15,238,375 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What potential risks should be considered when using Waitlist Control?

"Since Waitlist Control is currently in its Phase 1 trials, there is limited data on both safety and efficacy. We rate the risk of this medication at a score of one."

Answered by AI

Are there still openings available for patients to participate in this clinical trial?

"From the data hosted on clinicaltrials.gov, this study is presently accepting patients for trial participation. It was first published on February 1st 2023 and underwent its latest revision on September 20th of that year."

Answered by AI

How many individuals are eligible to partake in this research endeavor?

"Affirmative. The information found on clinicaltrials.gov establishes that this medical trial, first shared on February 1st 2023, is currently seeking participants. A total of 200 individuals are needed from a single site to be enrolled in the study."

Answered by AI

Who else is applying?

What site did they apply to?
San Francisco State University
What portion of applicants met pre-screening criteria?
Met criteria

Why did patients apply to this trial?

I find nature very rejuvenating.
PatientReceived no prior treatments
Recent research and studies
clinicaltrials.govStudy
Biological and Behavioral Outcomes of Community Nature Walks
Charlotte Tate 2023. "Biological and Behavioral Outcomes of Community Nature Walks". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06056375.
~57 spots leftby Nov 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top